Regulation of Inflammation by IL-17A and IL-17F Modulates Non-Alcoholic Fatty Liver Disease Pathogenesis
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease worldwide. While it is well-accepted that inflammation is central to NAFLD pathogenesis, the immune pathway(s) orchestrating disease progression are poorly defined. Notably, IL-17RA signaling, via IL-17A, plays an important role in obesity-driven NAFLD pathogenesis. However, the role of the IL-17F, another IL-17RA ligand, in NAFLD pathogenesis has not been examined. Further, the cell types expressing IL-17RA and producing IL-17RA ligands in the pathogenesis of NAFLD have not been defined. Here, IL-17RA-/-, IL-17A-/-, IL-17F-/- and wild-type (WT) mice were fed either standard chow diet or methionine and choline deficient diet (MCDD)--a diet known to induce steatosis and hepatic inflammation through beta-oxidation dysfunction--and hepatic inflammation and NAFLD progression were subsequently quantified. MCDD feeding augmented hepatic IL-17RA expression and significantly increased hepatic infiltration of macrophages and IL-17A and IL-17F producing CD4+ and CD8+ T cells in WT mice. In contrast, IL-17RA-/-, IL-17A-/-, and IL-17F-/- mice, despite increased steatosis, exhibited significant protection from hepatocellular damage compared to WT controls. Protection from hepatocellular damage correlated with decreased levels of hepatic T-cell and macrophage infiltration and decreased expression of inflammatory mediators associated with NAFLD. In sum, our results indicate that the IL-17 axis also plays a role in a MCDD-induced model of NAFLD pathogenesis. Further, we show for the first time that IL-17F, and not only IL-17A, plays an important role in NAFLD driven inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CD4 + T H 17 cells and CD8 + T cells have been shown to mediate NASH-associated liver fibrosis in both mice and humans (5-9).”
From NKG2D-mediated detection of metabolically stressed hepatocytes by innate-like T cells is essential for initiation of NASH and fibrosis (2023) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689 · cited 1×
“This increased expression of IL-17RA correlated with a significant increase in hepatic CD11b+F4/ 80+ macrophage infiltration and a trend towards increased macrophage skewing to a proinflammatory phenotype [21] as quantified by macrophage Ly6C expression (Fig 1D and data not shown).”
BackgroundThe IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J. (2014) · Nature reviews. Immunology · doi:10.1038/nri3707 · Cited by 1,585 · cited 2×
“Notably, multiple clinical trials are currently employing the use of IL17A and IL-17RA antibodies for a variety of diseases [27].”
BackgroundInnate IL-17-producing cells: the sentinels of the immune system
Cua, D. J., & Tato, C. M. (2010) · Nature Reviews Immunology · doi:10.1038/nri2800 · Cited by 1,578
Structure and signalling in the IL-17 receptor family
Gaffen, S. L. (2009) · Nature reviews. Immunology · doi:10.1038/nri2586 · Cited by 1,475 · cited 3×
“Of interest, IL-17A and IL-17F signal through a heterodimeric receptor consisting of both IL-17RA and IL-17RC subunits [6].”
BackgroundNonalcoholic Fatty Liver Disease: Pathology and Pathogenesis
Tiniakos, D. G., Vos, M. B., & Brunt, E. M. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102132 · Cited by 870 · cited 4×
“NAFLD represents a spectrum of disorders ranging from steatosis (benign fat accumulation) to nonalcoholic steatohepatitis (NASH) and cirrhosis [1].”
BackgroundInfluentialKarlmark, K. R., Weiskirchen, R., Zimmermann, H. W., Gassler, N., Ginhoux, F., Weber, C., Merad, M., Luedde, T., Trautwein, C., & Tacke, F. (2009) · Hepatology · doi:10.1002/hep.22950 · Cited by 782 · cited 1×
“Importantly, proinflammatory macrophage infiltration has been associated with induction of hepatic inflammation and hepatocellular damage[22, 23].”
BackgroundMouse models in non‐alcoholic fatty liver disease and steatohepatitis research
Anstee, Q. M., & Goldin, R. D. (2006) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2006.00465.x · Cited by 714 · cited 1×
“Of note, the MCDD is known to robustly upregulate hepatic inflammation [32].”
BackgroundMeng, F., Wang, K., Aoyama, T., Grivennikov, S. I., Paik, Y., Scholten, D., Cong, M., Iwaisako, K., Liu, X., Zhang, M., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.049 · Cited by 711
Baeck, C., Wehr, A., Karlmark, K. R., Heymann, F., Vucur, M., Gassler, N., Huss, S., Klussmann, S., Eulberg, D., Luedde, T., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300304 · Cited by 609 · cited 1×
“Hepatic macrophage recruitment during NAFLD has been shown to be mediated by CCL2 production, a potent macrophage chemokine shown to be produced in response to CXCL10 expression [2, 33, 36].”
BackgroundZhang, J.-P., Yan, J., Xu, J., Pang, X.-H., Chen, M.-S., Li, L., Wu, C., Li, S.-P., & Zheng, L. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.033 · Cited by 535 · cited 1×
“Notably, IL-17A levels correlate with a variety of human hepatic disorders, including alcoholic liver disease [7], primary biliary cirrhosis [8], chronic hepatitis B and C [9, 10], liver transplant rejection [11] and hepatocellular carcinoma [12].”
BackgroundIL-17 cytokines in immunity and inflammation
Jin, W., & Dong, C. (2013) · Emerging Microbes & Infections · doi:10.1038/emi.2013.58 · Cited by 529 · cited 2×
“IL-17RA is expressed ubiquitously, including expression by resident liver cells [7, 15].”
BackgroundSelf-citationZigmond, E., Samia-Grinberg, S., Pasmanik-Chor, M., Brazowski, E., Shibolet, O., Halpern, Z., & Varol, C. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400574 · Cited by 480 · cited 1×
“Importantly, proinflammatory macrophage infiltration has been associated with induction of hepatic inflammation and hepatocellular damage[22, 23].”
BackgroundMechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet
Rinella, M. E., Elias, M. S., Smolak, R. R., Fu, T., Borensztajn, J., & Green, R. M. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800042-jlr200 · Cited by 451
Hepatic Lipid Partitioning and Liver Damage in Nonalcoholic Fatty Liver Disease
Li, Z. Z., Berk, M., McIntyre, T. M., & Feldstein, A. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807616200 · Cited by 400 · cited 1×
“Notably, SCD-1 deficient mice exhibit decreased steatosis, but increased hepatocellular damage during MCDD feeding [31].”
BackgroundThe interleukin-17 pathway is involved in human alcoholic liver disease # †
Lemmers, A., Moreno, C., Gustot, T., Maréchal, R., Degré, D., Demetter, P., de Nadai, P., Geerts, A., Quertinmont, E., Vercruysse, V., et al. (2009) · Hepatology · doi:10.1002/hep.22680 · Cited by 394 · cited 2×
“Notably, IL-17A levels correlate with a variety of human hepatic disorders, including alcoholic liver disease [7], primary biliary cirrhosis [8], chronic hepatitis B and C [9, 10], liver transplant rejection [11] and hepatocellular carcinoma [12].”
BackgroundIL-17 regulates adipogenesis, glucose homeostasis, and obesity
Zúñiga, L. A., Shen, W.-J., Joyce-Shaikh, B., Pyatnova, E. A., Richards, A. G., Thom, C., Andrade, S. M., Cua, D. J., Kraemer, F. B., & Butcher, E. C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001269 · Cited by 394 · cited 1×
“While a role for IL-17A in obesity-related diseases has been previously described [3, 46], the role demonstrated herein for IL-17F is completely novel.”
BackgroundEvolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation
Peverill, W., Powell, L., & Skoien, R. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15058591 · Cited by 376 · cited 10×
“Currently, only limited therapies for NAFLD exist [2].”
BackgroundInfluentialKohli, R., Kirby, M., Xanthakos, S. A., Softic, S., Feldstein, A. E., Saxena, V., Tang, P. H., Miles, L., Miles, M. V., Balistreri, W. F., et al. (2010) · Hepatology · doi:10.1002/hep.23797 · Cited by 376
Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105
Divanovic, S., Trompette, A., Atabani, S. F., Madan, R., Golenbock, D. T., Visintin, A., Finberg, R. W., Tarakhovsky, A., Vogel, S. N., Belkaid, Y., et al. (2005) · Nature Immunology · doi:10.1038/ni1198 · Cited by 370
Self-citationA novel heterodimeric cytokine consisting of IL-17 and IL-17F regulates inflammatory responses
Chang, S. H., & Dong, C. (2007) · Cell Research · doi:10.1038/cr.2007.35 · Cited by 280 · cited 1×
“In fact, the heterodimeric complex of IL-17A/F has been shown to regulate inflammatory responses [47].”
BackgroundSelf-citationIL-17 Signaling Accelerates the Progression of Nonalcoholic Fatty Liver Disease in Mice
Harley, I. T. W., Stankiewicz, T. E., Giles, D. A., Softic, S., Flick, L. M., Cappelletti, M., Sheridan, R., Xanthakos, S. A., Steinbrecher, K. A., Sartor, B. R., et al. (2014) · Hepatology · doi:10.1002/hep.26746 · Cited by 250 · cited 7×
“Single cell suspensions were derived from hepatic digestion as described and stained with directly conjugated monoclonal antibodies or isotype controls (all eBioscience) [3, 17].”
BackgroundMethodSelf-citationZhang, X., Shen, J., Man, K., Chu, E. S. H., Yau, T. O., Sung, J. C. Y., Go, M. Y. Y., Deng, J., Lu, L., Wong, V. W. S., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.006 · Cited by 221 · cited 11×
“Given that: (a) IL-17A has a causal role in multiple models of liver injury; (b) IL-17F shares a receptor with IL-17A; and (c) IL-17RA mice are protected from obesity-induced NASH, we hypothesized that both IL-17A and IL-17F signaling through IL-17RA is critical to NAFLD progression.”
BackgroundInfluentialIL-23 Drives Pathogenic IL-17-Producing CD8+ T Cells
Ciric, B., El-behi, M., Cabrera, R., Zhang, G.-X., & Rostami, A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900036 · Cited by 221
Itagaki, H., Shimizu, K., Morikawa, S., Ogawa, K., & Ezaki, T. (2013) · Europe PMC (PubMed Central) · Cited by 217
Hepatic IL-17 responses in human and murine primary biliary cirrhosis
Lan, R. Y. Z., Salunga, T. L., Tsuneyama, K., Lian, Z.-X., Yang, G.-X., Hsu, W., Moritoki, Y., Ansari, A. A., Kemper, C., Price, J., et al. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.11.001 · Cited by 202 · cited 1×
“Notably, IL-17A levels correlate with a variety of human hepatic disorders, including alcoholic liver disease [7], primary biliary cirrhosis [8], chronic hepatitis B and C [9, 10], liver transplant rejection [11] and hepatocellular carcinoma [12].”
BackgroundGenetic modifiers of the phenotype of mice deficient in mitochondrial superoxide dismutase
Huang, T.-T., Naeemuddin, M., Elchuri, S., Yamaguchi, M., Kozy, H. M., Carlson, E. J., & Epstein, C. J. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl034 · Cited by 190 · cited 1×
“All mice were male, on a C57BL/6 background and were matched for nicotinamide nucleotide transhydrogenase (Nnt) mutation status [16].”
MethodYamaguchi, K., Itoh, Y., Yokomizo, C., Nishimura, T., Niimi, T., Fujii, H., Okanoue, T., & Yoshikawa, T. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.75 · Cited by 143 · cited 1×
“However, previous reports have demonstrated that inflammatory mediators associated with activation of IL-17 axis, IL-6 specifically, can regulate NAFLD pathogenesis in part via regulation of lipogenic machinery [28].”
Background板垣, 裕. (2012) · Institutional Repositories DataBase (IRDB) · Cited by 124
Opposing Biological Functions of Tryptophan Catabolizing Enzymes During Intracellular Infection
Divanovic, S., Sawtell, N. M., Trompette, A., Warning, J. I., Dias, A., Cooper, A. M., Yap, G. S., Arditi, M., Shimada, K., DuHadaway, J. B., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir621 · Cited by 116
Self-citationCurcumin limits the fibrogenic evolution of experimental steatohepatitis
Vizzutti, F., Provenzano, A., Galastri, S., Milani, S., Delogu, W., Novo, E., Caligiuri, A., Zamara, E., Arena, U., Laffi, G., et al. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.112 · Cited by 115
Trujillo, G., O'Connor, E. C., Kunkel, S. L., & Hogaboam, C. M. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070832 · Cited by 100
Fábrega, E., López‐Hoyos, M., Segundo, D. S., Casafont, F., & Pons‐Romero, F. (2009) · Liver Transplantation · doi:10.1002/lt.21724 · Cited by 99 · cited 1×
“Notably, IL-17A levels correlate with a variety of human hepatic disorders, including alcoholic liver disease [7], primary biliary cirrhosis [8], chronic hepatitis B and C [9, 10], liver transplant rejection [11] and hepatocellular carcinoma [12].”
BackgroundIL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression
Giles, D., Moreno-Fernandez, M., & Divanovic, S. (2015) · Current Drug Targets · doi:10.2174/1389450116666150531153627 · Cited by 95 · cited 1×
“IL-17A, the best described and characterized family member, is produced largely in the skin, mucosal tissues and liver [5, 6].”
BackgroundSelf-citationLu, L., Pan, K., Zheng, H.-X., Li, J.-J., Qiu, H.-J., Zhao, J.-J., Weng, D.-S., Pan, Q.-Z., Wang, D.-D., Jiang, S.-S., et al. (2013) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3182a802cf · Cited by 95 · cited 2×
“While previous studies have demonstrated that IL-17A signaling directly induces CXCL10 production in esophageal cell lines [34], and the production of IL-17F is necessary for CXCL10 expression in hepatic viral infection models [35], whether the IL-17 axis induces CXCL10 during NAFLD remains undefined.”
BackgroundDu, W.-J., Zhen, J.-H., Zeng, Z.-Q., Zheng, Z.-M., Xu, Y., Qin, L.-Y., & Chen, S.-J. (2013) · Diagnostic Pathology · doi:10.1186/1746-1596-8-40 · Cited by 93 · cited 1×
“Notably, IL-17A levels correlate with a variety of human hepatic disorders, including alcoholic liver disease [7], primary biliary cirrhosis [8], chronic hepatitis B and C [9, 10], liver transplant rejection [11] and hepatocellular carcinoma [12].”
BackgroundIL-17 inhibits adipogenesis in part via C/EBPα, PPARγ and Krüppel-like factors
Ahmed, M., & Gaffen, S. L. (2013) · Cytokine · doi:10.1016/j.cyto.2012.12.007 · Cited by 86
Alam, S., Gupta, U. D., Alam, M., Kabir, J., Chowdhury, Z. R., & Alam, A. K. M. K. (2014) · Indian Journal of Gastroenterology · doi:10.1007/s12664-014-0488-5 · Cited by 84
Identity crisis of Th17 cells: many forms, many functions, many questions
Sundrud, M. S., & Trivigno, C. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.021 · Cited by 77 · cited 2×
“In a variety of diseases, including Crohn’s disease, multiple sclerosis, and rheumatoid arthritis, levels of pro-inflammatory Th17 cells are known to be highly upregulated in the inflamed tissues compared to peripheral blood [44].”
BackgroundCritical role of interleukin‐17/interleukin‐17 receptor axis in mediating Con A‐induced hepatitis
Yan, S., Wang, L., Liu, N., Wang, Y., & Chu, Y. (2012) · Immunology & Cell Biology · doi:10.1038/icb.2011.59 · Cited by 73 · cited 1×
“Additionally, IL-17A drives multiple hepatic diseases in murine models, including Con A-induced hepatitis [13] and carbon tetrachloride-induced liver injury [14].”
BackgroundLiu, Y., She, W., Wang, F., Li, J., Wang, J., & Jiang, W. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.09.024 · Cited by 65 · cited 4×
“While a role for CD8 T cell production of IL-17A or IL-17F has not been previously described in hepatic diseases, CD4 T cells (Th17 cells) are known to be substantial producers of hepatic IL-17 levels [10, 26].”
BackgroundInfluentialXu, R., Tao, A., Zhang, S., & Zhang, M. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt065 · Cited by 63
Jie, Z., Liang, Y., Hou, L., Dong, C., Iwakura, Y., Soong, L., Cong, Y., & Sun, J. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303281 · Cited by 46 · cited 2×
“While previous studies have demonstrated that IL-17A signaling directly induces CXCL10 production in esophageal cell lines [34], and the production of IL-17F is necessary for CXCL10 expression in hepatic viral infection models [35], whether the IL-17 axis induces CXCL10 during NAFLD remains undefined.”
BackgroundSelf-citationTh17 and IL-17 immunity in chronic hepatitis C infection.
Balanescu, P. C., Lădaru, A., Voiosu, T. A., Nicolau, A., Ene, M., & Balanescu, A. (2012) · PubMed · Cited by 37
Wang, A., Yang, Z., Grinchuk, V., Smith, A. D., Qin, B., Lü, N., Wang, D., Wang, H., Ramalingam, T. R., Wynn, T. A., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500337 · Cited by 35 · cited 1×
“In fact, a protective role for IL-17RA in NAFLD progression was recently shown to be dependent on IL-17E signaling [48].”
BackgroundPark, H.-S., Jeon, B. H., Woo, S. H., Leem, J., Jang, J. E., Cho, M. S., Park, I.-S., Lee, K., & Koh, E. H. (2011) · Molecules and Cells · doi:10.1007/s10059-011-0184-6 · Cited by 24 · cited 2×
“Together, these data suggest that IL-17 axis does not alter lipogenic pathways in context of MCDD feeding [29, 30].”
BackgroundProvenzano, A., Milani, S., Vizzutti, F., Delogu, W., Navari, N., Novo, E., Maggiora, M., Maurino, V., Laffi, G., Parola, M., et al. (2014) · Liver International · doi:10.1111/liv.12500 · Cited by 23
Chae, M. K., Park, S. G., Song, S. O., Kang, E. S., Soo, B., Lee, H. C., & Lee, B. (2012) · Experimental Diabetes Research · doi:10.1155/2012/762565 · Cited by 22
Rinella, M. E. (2011) · Hepatology · doi:10.1002/hep.24634 · Cited by 21
Therapeutic Enhancement of Protective Immunity during Experimental Leishmaniasis
Divanovic, S., Trompette, A., Ashworth, J. I., Rao, M. B., & Karp, C. L. (2011) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001316 · Cited by 9
Self-citation
Research works printed but not linked: 1
- F Meng, 2012, Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice, Gastroenterology, 143, 765, 10.1053/j.gastro.2012.05.049 · DOI · Paper page
Cited by
Immune cell-mediated features of non-alcoholic steatohepatitis
Huby, T., & Gautier, E. L. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00639-3 · Cited by 573
Peiseler, M., Schwabe, R., Hampe, J., Kubes, P., Heikenwälder, M., & Tacke, F. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.06.012 · Cited by 564
Adaptive immunity: an emerging player in the progression of NAFLD
Sutti, S., & Albano, E. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0210-2 · Cited by 374
The Alterations in and the Role of the Th17/Treg Balance in Metabolic Diseases
Zhang, S., Gang, X., Yang, S., Cui, M., Sun, L., Li, Z., & Wang, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.678355 · Cited by 263
The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity
Van Herck, M. A., Weyler, J., Kwanten, W. J., Dirinck, E. L., De Winter, B. Y., Francque, S. M., & Vonghia, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00082 · Cited by 238
“Conversely, other authors report an increase in steatosis when IL-17 functionality is inhibited (65, 67).”
BackgroundResultInfluential
Metadata
- Authors
- Giles, D. A., Moreno-Fernandez, M. E., Stankiewicz, T. E., Cappelletti, M., Huppert, S. S., Iwakura, Y., Dong, C., Shanmukhappa, S. K., & Divanovic, S.
- Affiliations
- Cincinnati Children's Hospital Medical Center (US)
- Research Institute for Biomedical Sciences, Tokyo University of Science (JP)
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Divanovic, Senad
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-02-19
- Volume
- 11
- Issue
- 2
- Pages
- e0149783
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4760740
- OpenAlex
- W2283265313
- Cited by
- 116
- References
- 49
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 13 · 2023: 12 · 2022: 12 · 2021: 25 · 2020: 7 · 2019: 8 · 2018: 9 · 2017: 11 · 2016: 7
- FWCI
- 10.87
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Cincinnati Children's Hospital Medical Center (P30DK078392, R01DK099222)
- National Institutes of Health (DK078392)
- Japan Society for the Promotion of Science (15H05787, 24220011)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK099222, P30DK078392)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- non-alcoholic fatty liver disease, IL-17A, IL-17F, liver inflammation, methionine-choline-deficient diet, steatosis, hepatocyte injury, macrophage infiltration, T cell infiltration
- MeSH terms
- Animals, Choline, Diet, Disease Models, Animal, Hepatitis, Macrophages, Male, Methionine, Mice, Inbred C57BL, T-Lymphocytes, Signal Transduction, Interleukin-17, Mice, Receptors, Interleukin-17, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.